We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Luminex Corporation

Luminex develops, manufactures, and markets biological testing technologies with applications in clinical diagnostics... read more Featured Products: More products

Download Mobile App




Noninvasive Test Identifies Childhood Metabolic Disease Risk

By LabMedica International staff writers
Posted on 25 Jun 2014
Print article
Luminex 100 multiplex analyzer
Multiplex analyzer (Photo courtesy of Luminex - A Diasorin Company)
Salivary biomarkers have been used as a tool for identifying children who are at risk for developing Type 2 diabetes (T2D).

The study of obesity-related metabolic syndrome or T2D in children is particularly difficult because of fear of needles; however a noninvasive approach to study inflammatory parameters in an at-risk population of children may provide proof-of-principle for future investigations of vulnerable subjects.

Scientists from the Forsyth Research Institute, Cambridge, MA, USA) working with colleague in Kuwait, evaluated metabolic differences in 744, 11-year old children selected from underweight, normal healthy weight, overweight and obese categories by analyzing fasting saliva samples for 20 biomarkers. Saliva supernatants were obtained following centrifugation and used for analyses.

All assays on the 744 saliva samples for the 20 biomarkers were performed on saliva supernatant using four multiplex magnetic bead panels on a Luminex 100 platform (Luminex, Austin, TX, USA). A subset of 213 saliva supernatants (approximately 54 from each body weight category) were randomly selected and assayed for total protein. The assay was performed using the commercial kit Pierce 660 nm protein assay, (Pierce Biotechnology Rockford, IL, USA) which has a working range of 50 to 2,000 µg/ml. Protein values were determined on saliva supernatant samples using bovine serum albumin as a standard implemented on a robotic chemical analysis unit, the EVO 100 with a Sunrise spectrophotometer set at 660 nm, (Tecan US; Morrisville NC, USA).

Salivary C-reactive protein (CRP) was six times higher, salivary insulin and leptin were three times higher, and adiponectin was 30% lower in obese children compared to healthy normal weight children. Categorical analysis suggested that there might be three types of obesity in children. Distinctly inflammatory characteristics appeared in 76% of obese children while in 13%, salivary insulin was high but not associated with inflammatory mediators. The remaining 11% of obese children had high insulin and reduced adiponectin. In the non-obese children 40% were found in groups which, based on biomarker characteristics, may be at risk for becoming obese.

The authors concluded that they had identified four salivary biomarkers in their study subjects that change significantly with increasing obesity; insulin, CRP, adiponectin, and leptin. The results of this study suggest that obesity may be characterized and classified by salivary biomarker concentrations. The use of these relatively noninvasive markers, particularly in longitudinal studies, to investigate the development of metabolic diseases in children and to evaluate therapeutic interventions, could be used to develop prevention strategies. The study was published on June 10, 2014, in the journal Public Library of Science ONE.

Related Links:

Forsyth Research Institute
Luminex
Pierce Biotechnology 


New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Automated Blood Typing System
IH-500 NEXT
New
Lab Sample Rotator
H5600 Revolver
New
Chemistry Analyzer
MS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.